Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Whitehawk Therapeutics (WHWK) Other Non-Current Assets: 2018-2025

Historic Other Non-Current Assets for Whitehawk Therapeutics (WHWK) over the last 8 years, with Sep 2025 value amounting to $2.0 million.

  • Whitehawk Therapeutics' Other Non-Current Assets rose 30.50% to $2.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.0 million, marking a year-over-year increase of 30.50%. This contributed to the annual value of $1.4 million for FY2024, which is 25.03% down from last year.
  • According to the latest figures from Q3 2025, Whitehawk Therapeutics' Other Non-Current Assets is $2.0 million, which was down 7.70% from $2.1 million recorded in Q2 2025.
  • Whitehawk Therapeutics' Other Non-Current Assets' 5-year high stood at $2.3 million during Q1 2022, with a 5-year trough of $20,000 in Q1 2021.
  • Its 3-year average for Other Non-Current Assets is $1.8 million, with a median of $1.9 million in 2023.
  • As far as peak fluctuations go, Whitehawk Therapeutics' Other Non-Current Assets skyrocketed by 11,585.00% in 2022, and later fell by 25.03% in 2024.
  • Whitehawk Therapeutics' Other Non-Current Assets (Quarterly) stood at $2.2 million in 2021, then fell by 1.58% to $2.2 million in 2022, then decreased by 14.33% to $1.9 million in 2023, then fell by 25.03% to $1.4 million in 2024, then skyrocketed by 30.50% to $2.0 million in 2025.
  • Its Other Non-Current Assets was $2.0 million in Q3 2025, compared to $2.1 million in Q2 2025 and $1.4 million in Q1 2025.